Trials
Search / Trial NCT05646433

Validation of a New Score for UGI Bleeding in the ED: the Study of the TU-GIB Score

Launched by HÔPITAL UNIVERSITAIRE SAHLOUL · Dec 3, 2022

Trial Information

Current as of January 13, 2025

Recruiting

Keywords

Upper Gastro Intestinal Bleeding; Tu Gib Score; Ed

ClinConnect Summary

This clinical trial is studying a new scoring system called the TU-GIB Score, which helps doctors quickly identify patients with upper gastrointestinal (GI) bleeding who are at high risk for serious complications. This score is designed to be easy to use and reliable, allowing healthcare providers to make better decisions about treatment. So far, tests have shown that the TU-GIB Score performs better than an existing score (the Glasgow-Blatchford score) in predicting issues like rebleeding and the need for emergency treatments.

To participate in this trial, you must be over 18 years old and have come to the emergency room due to upper GI bleeding that is not caused by an injury. Unfortunately, younger patients, those with lower GI bleeding, or certain other conditions won't be eligible. If you choose to participate, you will help researchers validate this new scoring system in various emergency departments, which could improve care for future patients facing similar issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients consulting the emergency room for upper GI hemorrhage of non-traumatic origin.
  • Age \>18 years
  • Exclusion Criteria:
  • patient under the age of 18
  • Lower gastrointestinal hemorrhag
  • diagnosis of external hemorrhoids / perianal lesions
  • Not consenting
  • The lost sight

About Hôpital Universitaire Sahloul

Hôpital Universitaire Sahloul is a leading academic medical institution located in Sousse, Tunisia, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital focuses on enhancing patient care and treatment outcomes across various medical disciplines. With a commitment to rigorous scientific methodology and ethical standards, Hôpital Universitaire Sahloul collaborates with multidisciplinary teams to conduct trials that contribute to the global medical community's understanding of diseases and therapeutic interventions. Its state-of-the-art facilities and expertise position it as a key player in the advancement of clinical research in the region.

Locations

Sousse, , Tunisia

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials